Literature DB >> 15661739

Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.

Jinyong Kim1, Savitha Sharma, Yamin Li, Everardo Cobos, Jorma J Palvimo, Simon C Williams.   

Abstract

CCAAT/enhancer-binding protein epsilon (C/EBPepsilon) is a neutrophil-specific transcription factor whose activity is controlled by juxtaposed activating and regulatory domains. We previously determined that the function of the major regulatory domain (RD1) in C/EBPepsilon was dependent on the integrity of a five-amino acid motif that was identical to the recognition site for members of the small ubiquitin-like modifier (SUMO) family of ubiquitin-related proteins. We show here that the SUMO attachment site (the regulatory domain motif) is necessary and sufficient both for the intrinsic inhibitory function of RD1 and for coactivation by PIASxalpha and PIASxbeta, two members of the protein inhibitor of activated STAT (PIAS) family of SUMO E3 ligases. PIASxbeta was a more potent coactivator than PIASxalpha of both full-length C/EBPepsilon and fusion proteins containing the N-terminal portion of C/EBPepsilon, whereas PIASxalpha was more active on fusion proteins containing a heterologous activation domain. Two modes of coactivation were observed, one that was dependent on the integrity of the RING finger (RF) domain and was shared by both PIASxalpha and PIASxbeta and a second mode that was independent of the RF and was only observed with PIASxbeta. Sumoylation of C/EBPepsilon was enhanced by coexpression of PIASxalpha, suggesting that this modification is associated with the enhanced activity of the target protein. These results suggest that a complex interplay of accessory factors, including SUMO and PIAS proteins, modulates the activity of C/EBPepsilon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661739     DOI: 10.1074/jbc.M413771200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

2.  C/EBPε participates in all-trans retinoic acid induction of PI3Kγ in U937 cells via an intronic matrix attachment region sequence.

Authors:  Rong Cai; Xia Cai; Bin Chen; Weirong Xu; Jian Lu
Journal:  Mol Biol Rep       Date:  2010-07-27       Impact factor: 2.316

Review 3.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

4.  PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.

Authors:  Shanggen Zhou; Junling Si; Tong Liu; James W DeWille
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

5.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.

Authors:  Richa Bedi; Jian Du; Arun K Sharma; Ignatius Gomes; Steven J Ackerman
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

6.  CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils.

Authors:  Nina K Serwas; Jakob Huemer; Régis Dieckmann; Ester Mejstrikova; Wojciech Garncarz; Jiri Litzman; Birgit Hoeger; Ondrej Zapletal; Ales Janda; Keiryn L Bennett; Renate Kain; Dontscho Kerjaschky; Kaan Boztug
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

7.  CCAAT/Enhancer-Binding Protein ε27 Antagonism of GATA-1 Transcriptional Activity in the Eosinophil Is Mediated by a Unique N-Terminal Repression Domain, Is Independent of Sumoylation and Does Not Require DNA Binding.

Authors:  Monika J Stankiewicz; Jian Du; Dominick Martinico; Steven J Ackerman
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.